(Q34714438)

4 August 2017

1 reference

title

HIV-1/AIDS and the control of other infectious diseases in Africa (English)

1 reference

4 August 2017

1 reference

Feiko O ter Kuile

3

0 references

Elizabeth L. Corbett

object named as

Elizabeth L Corbett

series ordinal

1

0 references

Richard J. Hayes

object named as

Richard J Hayes

series ordinal

6

0 references

Richard W Steketee

series ordinal

2

object named as

Richard W Steketee

1 reference

4 August 2017

5

Anatoli Kamali

1 reference

4 August 2017

Ahmed S Latif

4

1 reference

PubMed ID

12090997

4 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

4 August 2017

1 reference

4 August 2017

359

1 reference

4 August 2017

2177-2187

1 reference

4 August 2017

9324

1 reference

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Concurrent infections and HIV pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Cofactors in male-female sexual transmission of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

The malaria burden and Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Royal Society of Tropical Medicine and Hygiene meeting at Manson House, London, 18 March 1999. Fresh from the field: some controversies in tropical medicine and hygiene. HIV and malaria, do they interact?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Is there an interaction between human immunodeficiency virus and Plasmodium falciparum?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

HIV and malaria: a lesson in immunology?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Malaria in pregnancy: its relevance to safe-motherhood programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Human immunodeficiency virus seropositivity and malaria as risk factors for third-trimester anemia in asymptomatic pregnant women in western Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Immunity to placental malaria. II. Placental antigen-specific cytokine responses are impaired in human immunodeficiency virus-infected women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

HIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

HIV infection may adversely affect clinical response to chloroquine therapy for uncomplicated malaria in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Plasmodium falciparum cross resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Chloroquine accumulates in breast-milk cells: potential impact in the prophylaxis of postnatal mother-to-child transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

The anti-HIV-1 activity of chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Estimated risk of HIV transmission by blood transfusion in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

The burden of malaria in pregnancy in malaria-endemic areas.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

A new global commitment to disease control in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Epidemiological Synergy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Antenatal HIV prevalence in Yaounde, Cameroon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 cell depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

The multicentre study on factors determining the differential spread of HIV in four African cities: summary and conclusions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Multicentre study on factors determining differences in rate of spread of HIV in sub-Saharan Africa: methods and prevalence of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Why do young women have a much higher prevalence of HIV than young men? A study in Kisumu, Kenya and Ndola, Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Improved treatment services significantly reduce the prevalence of sexually transmitted diseases in rural Tanzania: results of a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

How many patients with a sexually transmitted infection are cured by health services? A study from Mwanza region, Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

High prevalence of trichomoniasis in rural men in Mwanza, Tanzania: results from a population based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Complementary hypothesis concerning the community sexually transmitted disease mass treatment puzzle in Rakai, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Rates of HIV-1 transmission within marriage in rural Uganda in relation to the HIV sero-status of the partners

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Syndromic treatment of sexually transmitted diseases reduces the proportion of incident HIV infections attributable to these diseases in rural Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Male circumcision: assessment of health benefits and risks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Tuberculosis control and molecular epidemiology in a South African gold-mining community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in rural Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Impact of social interactions in the community on the transmission of tuberculosis in a high incidence area

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Tuberculosis and the HIV epidemic: increasing annual risk of tuberculous infection in Kenya, 1986-1996

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Changing Clinical Presentation and Survival in HIV-Associated Tuberculosis After Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Community infection ratio as an indicator for tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

Sniffing out the truth: clinical diagnosis using the electronic nose

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909095-5

7 January 2021

10.1016/S0140-6736(02)09095-5

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12090997